11. AB0084 Breadth of baseline autoantibody profile and treatment response in rheumatoid arthritis patients. (15th June 2017) Authors: Derksen, VFAM; Moel, EC de; Trouw, LA; Goekoop, RJ; Speyer, I; Huizinga, TWJ; Allaart, CF; Toes, REM; Woude, D van der Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Issue 1 (5th May 2012) Authors: Dougados, Maxime; Kissel, Karsten; Sheeran, Tom; Tak, Paul P; Conaghan, Philip G; Mola, Emilio Martín; Schett, Georg; Amital, Howard; Navarro-Sarabia, Federico; Hou, Antony; Bernasconi, Corrado; Huizinga, TWJ Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 1(2013) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Aesthetic dissatisfaction in patients with hand osteoarthritis and its impact on daily life. (3rd May 2016) Authors: Liu, R; Damman, W; Beaart-van de Voorde, LJJ; Kaptein, AA; Rosendaal, FR; Huizinga, TWJ; Kloppenburg, M Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 3(2016) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis. (4th July 2018) Authors: Baecklund, E; Backlin, C; Rönnelid, J; Toes, R; Huizinga, TWJ; Åhlin, E; Askling, J; Hochberg, FH; Klareskog, L; Kay, J; Smedby, KE Journal: Scandinavian journal of rheumatology Issue: Volume 47:Number 4(2018) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Issue 4 (10th February 2020) Authors: Kissel, T; Reijm, S; Slot, LM; Cavallari, M; Wortel, CM; Vergroesen, RD; Stoeken-Rijsbergen, G; Kwekkeboom, JC; Kampstra, ASB; Levarht, EWN; Drijfhout, JW; Bang, H; Bonger, KM; Janssen, GMC; van Veelen, PA; Huizinga, TWJ; Scherer, HU; Reth, M; Toes, REM Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 4(2020) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. (May 2013) Authors: Knevel, R; Tsonaka, R; le Cessie, S; van der Linden, MPM; Huizinga, TWJ; van der Heijde, DMFM; Houwing-Duistermaat, JJ; van der Helm-van Mil, AHM Journal: Scandinavian journal of rheumatology Issue: Volume 42:Number 3(2013) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial. Issue 1 (25th March 2016) Authors: Akdemir, G; Markusse, IM; Dirven, L; Riyazi, N; Steup-Beekman, GM; Kerstens, PJSM; Lems, WF; Huizinga, TWJ; Allaart, CF Journal: RMD open Issue: Volume 2:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Evaluating joint destruction in rheumatoid arthritis: is it necessary to radiograph both hands and feet?. Issue 3 (12th May 2012) Authors: Knevel, R; Kwok, KY; de Rooy, DPC; Posthumus, MD; Huizinga, TWJ; Brouwer, E; van der Helm-van Mil, AHM Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 3(2013) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. FRI0090 Analysis of neutrophils, lymphocytes, and platelets in pooled phase 2 and phase 3 studies of baricitinib for rheumatoid arthritis. (15th June 2017) Authors: Kremer, J; Huizinga, TWJ; Chen, L; Saifan, CG; Issa, M; Witt, SL; Walls, CD; Torre, I de la Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?. (3rd September 2018) Authors: Torrente-Segarra, V; Bergstra, SA; Solomon-Escoto, K; Da Silva, JAP; Veale, DJ; Al-Emadi, S; Huizinga, TWJ Journal: Scandinavian journal of rheumatology Issue: Volume 47:Number 5(2018) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗